Hypoglykæmi I forsøg med patienter, som fik behandling med BYETTA og sulfonylurinstof (med eller uden metformin), blev incidensen af hypoglykæmi forøget i forhold til placebo (23, 5% og 25, 2% i forhold
Hypoglycaemia In studies in patients treated with BYETTA and a sulphonylurea (with or without metformin), the incidence of hypoglycaemia was increased compared to placebo (23.5% and 25.2% versus 12.6% and 3.3%) and appeared to be dependent on the doses of both BYETTA and the sulphonylurea.